Skip to content
Review

Recent Advances in Dendrimers as Potential Therapeutic Delivery Systems

Sep 2026 · Russian journal of bioorganic chemistry · Vol 52 · 0 citations · 84 references

TL;DR

This review comprehensively examines recent advancements in dendrimer-mediated delivery systems, elucidating their capacity to optimize solubility, enhance bioavailability, and facilitate the site-specific targeting of therapeutic payloads and offers crucial insights into overcoming translational bottlenecks in targeted therapy.

View source

Similar papers

Review Aug 2026

Dendrimer-Based Nanoplatforms for Cancer Diagnosis and Therapy: from Liquid Biopsy to Targeted Protein Degradation

Dendrimer-based systems have shown considerable potential to remodel the tumor microenvironment, induce immunogenic cell death, enhance immune activation, and facilitate combination therapies, offering promising opportunities to improve cancer diagnosis, treatment, and patient outcomes.

Mahsa Hasannejad Alibaglou, Zeinab Chaharlashkar, Fateme Bina et al. · 0 citations
Review Aug 2026

Dendrimers in precision oncology: advances in therapy, diagnostics, and translational prospects.

Dendrimers are highly branched nanoscale macromolecules with precisely tunable architectures that have emerged as transformative tools in cancer research. Their unique properties, such as high drug-loading capacity, multivalency, and surface tailoring ability, enable innovative applications in drug delivery, gene thera...

Davood Zaeifi, K. Jamialahmadi, G. Karimi · 1 citation
Review Sep 2026

Chitosan Nanoparticles: Preparation Methods and Medical Applications

This review delivers a rigorous and comprehensive systematic overview of contemporary ChNP fabrication methodologies alongside their primary medicinal applications, focusing on targeted drug delivery, oncological interventions, and the treatment of diverse pathological conditions via intrinsic antimicrobial pathways.

E. Gomaa · 0 citations
Review Open access Sep 2026

Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches

This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...

C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al. · 0 citations
Review Open access Sep 2026

Recent advances in boron containing anticancer drug delivery nanocarrier platforms

Boron-containing compounds have emerged as versatile building blocks in the design of advanced anticancer drug delivery systems due to their unique chemical features, including electron deficiency, reversible covalent interactions, and structural diversity. In recent years, significant progress has been made in enginee...

M. Nakipoğlu · 0 citations
Open access Sep 2026

Innovative nanomedicine strategies for precision-controlled targeted drug delivery: recent preclinical progress

Current preclinical evidence supports nanomedicine as a central pillar of precision drug delivery, with future progress expected to focus on adaptive, multifunctional, and patient-specific platforms that align with the principles of personalized medicine.

Ashna Sureshkumar, P. Balu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.